Clinical Trials Directory

Trials / Completed

CompletedNCT05357859

Vitamin D for Cognition in Bipolar Disorder

Effect of Vitamin D Supplement for Cognitive Function in Patients With Bipolar Disorder- Randomized Double-Blind Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
21 (actual)
Sponsor
Taipei City Hospital · Other Government
Sex
All
Age
20 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Conduct randomized double-blind controlled trial (RCT), to examine the effects of vitamin D on cognitive performance in euthymic BD.

Detailed description

Bipolar disorder (BD) is a chronic mental disease related to recurrent episodes along with cognitive or functional decline. Comparing efficacy of pharmacological interventions targeting to treat cognitive deficit in BD is unexplored. The majority of the observational studies demonstrate a significant association between low serum vitamin D and compromised cognition in a wide range of neuropsychiatry diseases. Recent survey further revealed the high prevalence of hypovitamin D in BD. The effect of supplement and association between vitamin D and cognition in BD and the underlying mechanism is unclear. The investigators will collect vitamin D levels and assess their association with cognition in a euthymic bipolar cohort (N=200) for screen. Then, the investigators estimate to recruit 120 of participants with cognitive deficits and combined vitamin D deficiency, to conduct a RCT. Participants will keep their usual treatment and will be randomized to receive either vitamin D supplement or a placebo for eight weeks. Cognitive test, adverse side effect, mood status and blood 25(OH)D levels and biomarkers will be measured before and after intervention.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTsolubilized vitamin D3solubilized vitamin D3
DIETARY_SUPPLEMENTmedium chain triglycerideMCT with same amount

Timeline

Start date
2022-05-03
Primary completion
2023-11-17
Completion
2023-11-20
First posted
2022-05-03
Last updated
2023-11-22

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT05357859. Inclusion in this directory is not an endorsement.